OClawVPS.com
JumpCloud
Edit

JumpCloud

https://jumpcloud.com/
Last activity: 30.03.2026
Active
Categories: CloudDevOpsEmployeeFinTechHardwareITManagementPlatformSecurityService
JumpCloud is reimagining the on-prem directory as a cloud-based platform that secures identities, manages devices, and provides safe access to all types of IT resources — on-prem, in the cloud, across Windows, Mac, or Linux.

Set up a JumpCloud Free account to try the full platform for free today. You get 10 users, 10 devices, and 10 days of premium 24x7 in-app chat support to get you started.
Likes
2.11K
Followers
16.16K
Website visits
1.4M /mo.
Mentions
187
Location: United States, Colorado, Louisville
Employees: 201-500
Phone: +1 720-240-5005
Total raised: $622.1M
Valuation: $2.56B
Founded date: 2012

Investors 18

Show more

Funding Rounds 7

DateSeriesAmountInvestors
21.10.2021Series F$225MNTT Docomo...
13.09.2021Series F$159M-
12.01.2021Series E$100MGeneral At...
13.11.2020Series E$75M-
27.05.2019-$50MGeneral At...
05.09.2018-$10M-
23.01.2014Series A$3.1M-

Mentions in press and media 187

DateTitleDescription
30.03.2026Cyber-risk Doesn’t Follow The News Cycle; We Can’t Let Our Vigilance do The SameBy now, UK businesses are well aware of the impact global tensions can have. It feels almost impossible to scan the headlines without seeing another tariff dispute, escalating conflict or shift in global trade – each carrying its own implic...
07.03.2026Hexnode debuts device-aware IdP to fuse identity & UEM-
11.02.2026JumpCloud Launches Venture Arm And Backs Identity-Fraud Startup TofuJumpCloud has launched JumpCloud Ventures, a new venture arm that supports early-stage companies building identity, security, AI, and IT productivity solutions. The company framed the program as a long-term effort to help advance foundation...
22.01.2026Exciva Secures €51 Million Series B: Alzheimer's Agitation Therapy Advances to Phase 2Exciva closed a €51 million Series B funding round. This financing fuels Deraphan, its Alzheimer's agitation therapy, into crucial Phase 2 trials. EQT Life Sciences and Gimv spearheaded the investment. The global study addresses a pressing ...
20.01.2026JumpCloud Acquires MacSolutionJumpCloud, a Louisville, CO-based provider of a unified identity, device, and access management platform, acquired MacSolution, a Sao Paulo, Brazil-based managed service provider (MSP) of JumpCloud in the Americas. The amount of the deal wa...
20.01.2026Exciva raises €51M in Series B FundingExciva, a Heidelberg, Germany-based biopharmaceutical company developing new therapeutic compounds for the treatment of neuropsychiatric conditions, raised €51M in Series B funding. The round was led by Gimv and EQT Life Sciences. Additiona...
20.01.2026Robin Health Closes €2M Pre-Seed FundingRobin Health, a Milan, Italy-based healthtech startup focused on prevention and digital health management, raised €2M in Pre-Seed funding. The round was led by Step Fund. The company intends to use the funds to expand operations and its dev...
15.01.2026JumpCloud AI Capabilities Secure Every Identity and Unlock Enterprise Productivityis unveiling new AI capabilities to fuel safe innovation. Organizations can leverage JumpCloud’s platform to accelerate AI adoption. They can ensure compliance and control for all types of identity—human, non-human, and autonomous agents. G...
08.01.2026JumpCloud expands Latin America presence with MacSolution acquisition Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE CookiesJumpCloud Inc., a platform for identity, access and devices, today announced that it has acquired MacSolution Tecnologia Ltd., the largest managed service provider in the Americas and an existing JumpCloud partner, for an undisclosed price....
02.01.2026Ни единого разрыва с TUN/TAP, или как я боролся с «подзатупами» интернета на островеНекоторое время назад я обнаружил, что мой доселе чистый и светлый интернет стал подвержен проблеме, которую лично я охарактеризовал как "подзатупы". Суть "подзатупов" заключается в сериях из пауз передачи пакетов длиной...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In